Antibiotics in a Baby’s First Month Quadruple Food Allergy Odds, Study Finds
Researchers pooled 190 observational studies covering roughly 2.75 million children in 40 countries to rank what actually tracks with childhood food allergy. Antibiotics in the first month of life topped the list at an odds ratio of 4.11, followed by infant eczema and delayed peanut introduction. Low birth weight, partial breastfeeding and maternal diet in pregnancy showed no significant link at all.
If you have ever wondered whether something in your child's first year nudged them toward a food allergy – a course of antibiotics for an ear infection, a stubborn patch of eczema, a cautious decision to hold off on peanut butter – a new analysis finally puts numbers on that question. Researchers pooled 190 observational studies covering roughly 2.75 million children across 40 countries and ranked what actually tracks with developing a food allergy. The strongest signals cluster around the immune system's earliest environmental encounters: the gut microbiome, the skin barrier, and the timing of first food exposures. Several things parents are routinely warned about showed no measurable link at all.
Key Takeaways
- Antibiotics in the first month of life carried the highest odds of any modifiable factor examined, at an odds ratio of 4.11, followed by infant eczema (3.88) and delaying peanut introduction past 12 months (2.55).
- About 4.7% of children develop a food allergy by age 6, so even large odds ratios translate into absolute risk increases in the single digits to low teens.
- Low birth weight, partial breastfeeding, and maternal diet during pregnancy showed no significant association with food allergy, which quietly retires several long-standing worries.
- These are associations, not proven causes. All 190 studies were observational, and only 38 of 342 risk factors examined reached high-certainty evidence.
Early Antibiotics Top the Childhood Food Allergy Risk Ranking
The strongest modifiable risk factor for childhood food allergy in this analysis was antibiotic exposure in the first month of life, associated with an odds ratio of 4.11 and an absolute risk increase of 12.8 percentage points. The finding comes from a systematic review and meta-analysis published in JAMA Pediatrics on February 9, 2026, led by Nazmul Islam, Alexandro W. L. Chu and Falana Sheriff with senior author Derek Chu of McMaster University, and funded by the Canadian Institutes of Health Research together with the AAAAI/ACAAI Joint Task Force on Allergy Practice Parameters.
An odds ratio compares the odds of an outcome in an exposed group against an unexposed group, where 1.0 means no difference at all. By that measure, a newborn's first-month antibiotic course sat at the very top of a list of 342 candidate risk factors. It is a biologically coherent place to land: the first weeks of life are when the infant gut microbiome (the community of bacteria colonizing the digestive tract) assembles, and independent research has tied the infant gut bacterial microbiota to later pediatric asthma and allergic disease and early-life antibiotics to gut microbiome disruption and higher atopic dermatitis risk. Atopic dermatitis (eczema, a chronic inflammatory skin condition) in the first year of life followed closely at OR 3.88 and +12.0%, with allergic rhinitis or conjunctivitis at OR 3.39 and +10.1%.
Why Families Managing Eczema, Wheeze or Hay Fever Should Care
Children who already have eczema, wheezing or allergic rhinitis sit in the highest-risk band this analysis identified, and the pattern points at the skin rather than the diet. Beyond eczema itself, increased transepidermal water loss – a measurable leakiness of the skin barrier – carried an odds ratio of 3.36 (+10.0%), and mutations in the filaggrin gene, which encodes a protein that helps hold the outer skin layer together, came in at OR 1.93 (+4.2%).
That trio fits the dual allergen exposure hypothesis, the idea that food proteins meeting the immune system through inflamed, broken skin drive sensitization while the same proteins eaten early drive tolerance. Allergy researchers have been building skin and oral prevention strategies on that model for years, and this meta-analysis is consistent with it. Family history mattered too, though less than the skin: a sibling with food allergy carried OR 2.36, both parents with a food allergy history OR 2.07, and a mother with one OR 1.98. A history of wheezing sat at OR 2.11. Sex, birth order and delivery mode barely moved the needle by comparison – male sex at OR 1.24, cesarean delivery at OR 1.16, firstborn status at OR 1.13.
How 190 Studies and 2.75 Million Children Were Pooled
The analysis synthesized 190 observational studies – 156 cohort, 22 case-control and 12 cross-sectional – totaling roughly 2.75 million participants in 40 countries. The geographic spread was uneven: Europe contributed 36.8% of studies, the Americas 27.9%, Asia 16.3%, Australia and New Zealand 15.3%, the Middle East 3.2%, and Africa just 0.5%.
Two features make the result more useful than a single cohort. First, scale: pooling millions of children lets rare outcomes and modest effects separate from noise. Second, the team graded certainty rather than treating every association as equivalent. Of the 342 risk factors identified, 38 were rated high-certainty, 69 moderate, 120 low and 115 very low. The headline incidence figure – 4.7% of children with a food allergy by age 6 – was rated moderate-certainty. That grading is what lets a reader distinguish a finding worth acting on from a statistical curiosity.
What These Risk Factors Do and Do Not Tell a Parent
Nothing in this analysis establishes that avoiding a given exposure prevents food allergy, because no intervention was tested – these are observed patterns, not trials. The one area where the observational signal lines up with randomized evidence is timing of allergen introduction: delayed peanut introduction after 12 months carried OR 2.55 (+6.8%) here, and the randomized LEAP trial in the New England Journal of Medicine previously showed that early peanut consumption in high-risk infants reduced peanut allergy compared with avoidance. US practice already reflects that: the NIAID addendum guidelines on peanut allergy prevention recommend age-based early introduction, with the earliest and most careful approach reserved for infants with severe eczema or existing egg allergy.
The practical read for a parent is narrower than the headline suggests. If an infant has significant eczema, that is a reason to raise allergen introduction timing with a pediatrician or allergist rather than to improvise, since the highest-risk infants are exactly the ones the guidelines want assessed first. The antibiotic finding is not an argument against treating a genuine bacterial infection in a newborn; it is an argument for the antibiotic stewardship clinicians already practice. And nothing here supports any specific probiotic, supplement or elimination diet as a proven preventive – none were established by this evidence.
Observational Design and Risk of Bias Limit What Can Be Claimed
The central limitation is that every included study was observational, so each association could reflect confounding or reverse causation rather than a causal effect. 125 of the 190 studies (66.0%) were judged at high or probably-high risk of bias on at least one criterion, most often inconsistent measurement of the prognostic factors themselves. Notably, the authors found no credible subgroup differences by risk-of-bias tier, allergy definition, study era, or number of allergens assessed, which argues the overall picture is not an artifact of the weaker studies.
Two of the strongest associations demand careful reading rather than a biological interpretation. Self-identification as Black compared with White carried OR 3.93 (+12.1%), and parental migration before birth OR 3.28 (+9.7%). Those are markers of environment, exposure and healthcare access, not of biology, and treating them as innate would misread the data badly.
A Multifactorial Model Replaces the Search for One Cause
The authors' conclusion is that no single exposure explains childhood food allergy; they propose a multifactorial model combining genetics, skin barrier integrity, the microbiome and environmental exposure. The factors with the strongest associations and the most plausible mechanisms – early antibiotic exposure, skin barrier repair in infants with eczema, and allergen introduction timing – are the ones that can be tested in randomized trials, and only trials can convert these odds ratios into prevention advice. In the meantime, the 38 high-certainty factors are the reasonable basis for clinical conversation; the 235 rated low or very low are hypotheses.
Common Questions
Does an antibiotic in a newborn's first month cause food allergy? No – the study found an association (OR 4.11), not proof of cause, and all 190 included studies were observational. It is a reason to avoid unnecessary antibiotics, not a reason to refuse a needed one.
Does breastfeeding prevent food allergy? This analysis found no significant association between partial breastfeeding and food allergy. Breastfeeding has other well-documented benefits; food allergy prevention does not appear to be reliably among them based on this evidence.
Should a pregnant parent avoid allergenic foods? The analysis found no significant association between maternal fish or cheese intake during pregnancy and childhood food allergy, and none for maternal stress in pregnancy either. Restricting maternal diet is not supported here.
How common is childhood food allergy? About 4.7% of children had developed a food allergy by age 6 in this pooled data, a figure the authors rated moderate-certainty.
Evidence Rating
ESTABLISHED — 92/100
Caveats
- All 190 included studies were observational with no RCTs, so these are risk associations rather than proven single causes
- 66% of included studies carried some risk-of-bias concern
- Only 38 of 342 identified risk factors were rated high-certainty evidence
Based on a meta-analysis of 190 observational studies; the reported risk factors are strong statistical associations from cohort and case-control data, not causal proof, and most individual studies carried some methodological limitation.
References
- Islam N, Chu AWL, Sheriff F, et al. "Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis." JAMA Pediatrics, published online February 9, 2026. https://jamanetwork.com/journals/jamapediatrics/fullarticle/2844828
- "Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy" (LEAP). New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1414850
- "Guidelines for Clinicians and Patients for Diagnosis and Management of Food Allergy in the United States." National Institute of Allergy and Infectious Diseases (NIAID). https://www.niaid.nih.gov/diseases-conditions/guidelines-clinicians-and-patients-food-allergy
- "The Infant Gut Bacterial Microbiota and Risk of Pediatric Asthma and Allergic Diseases." National Library of Medicine, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5555614/
- "Skin and oral intervention for food allergy prevention based on dual allergen exposure hypothesis." National Library of Medicine, PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11471915/
- "Antibiotics taken within the first year of life are linked to infant gut microbiome disruption and elevated atopic dermatitis risk." Journal of Allergy and Clinical Immunology. https://www.jacionline.org/article/S0091-6749(24)00409-3/fulltext